Skip to main content
Clinical Trials/NCT06609317
NCT06609317RecruitingNot Applicable

Feasibility of Pelvic Floor Muscle Training With a Digital Therapeutic Motion-based Device (Leva Device) in a Postpartum Population

University of South Florida2 sites in 1 country25 target enrollmentStarted: April 4, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
25
Locations
2
Primary Endpoint
Feasibility

Study Overview

Brief Summary

The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.

In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.

Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Spontaneous vaginal delivery within the last 4-8 weeks
  • Age ≥ 18 years
  • Ambulatory
  • Willing and able to consent to participate.
  • English speaking
  • Owns a smartphone

Exclusion Criteria

  • Operative or cesarean delivery
  • Obstetric delivery at less than 20 weeks gestation
  • Third- or fourth-degree perineal laceration
  • Episiotomy
  • Multiples

Arms & Interventions

Device Arm

Experimental

Participants in this arm will use a digital therapeutic motion-based device for postpartum pelvic floor muscle training

Intervention: Digital therapeutic motion-based device (Device)

Outcomes

Primary Outcomes

Feasibility

Time Frame: From enrollment to 6 months postpartum

Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.

Perineal Pain

Time Frame: From enrollment to 6 months postpartum

Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.

Secondary Outcomes

  • Bladder function(From enrollment to 6 months postpartum)
  • Bowel Function(From enrollment to 6 months postpartum)
  • Pelvic Organ Prolapse(From enrollment to 6 months postpartum)
  • Vaginal pain(From enrollment to 6 months postpartum)
  • Sexual function(From enrollment to 6 months postpartum)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials